a double-blind trial with two parallel groups was carried out to compare the antispastic effect and tolerability of a new muscle relaxant , tizanidine ( ds 103-282 ) , with those of baclofen in the treatment of spasticity due to multiple sclerosis .
C0004609
baclofen
C0026838
spasticity